Catalyst Wire Dossier Catalyst Wire Dossier

ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension

ciprofloxacin; dexamethasone · Par Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension, covering 2017-09-26 to 2017-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes [Phase 3]

See pricing